Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Acta Neuropathol. 2009 Apr 28;117(6):613–634. doi: 10.1007/s00401-009-0538-8

Table 1.

General characteristics of the study subjects, by neuropathologic diagnosis, age, gender, apoE genotype and postmortem interval (PMI). Means and standard deviations (SD) are given. Thirty-four of the DLB cases and 27 of the PD cases also met neuropathologic diagnostic criteria for AD.

Diagnosis (N) Age (SD)1 Disease Duration, yrs (SD)2 Gender (%M)3 ApoE-ɛ4 (%)4 PMI, hrs Median, mean (SD)5
Normal (87) 84.8 (6.9) N/A 51.7 26.4 2.7, 3.3 (2.8)
ILBD (26) 86.6 (5.5) N/A 61.5 30.0 2.9, 3.1 (1.6)
PD (66) 79.1 (6.9) 10.6 (8.7) 69.7 30.3 2.7, 3.8 (3.3)
DLB (40) 80.7 (6.6) 6.9 (4.7) 65.0 55.0 3.1, 4.5 (4.7)
ADLB (85) 83.4 (8.1) 9.0 (4.7) 50.6 55.3 3.0, 6.0 (8.9)
ADNLB (113) 82.8 (9.5) 7.3 (4.7) 46.0 53.9 3.0, 6.3 (11.4)
1

Group means were significantly different (p < 0.0001).

2

Group means were significantly different (p = 0.003).

3

Subjects with ADNLB differed in gender distribution from those with PD and DLB (P < 0.01 for the comparison with PD, p < 0.05 for the comparison with DLB); subjects with ADLB differed from those with PD (p < 0.05).

4

Normal subjects and ILBD subjects differed from those with DLB, ADLB and ADNLB in the proportion that were apoE-ɛ4 positive (p < 0.01 for comparisons with normal, p < 0.05 for comparisons with ILBD).

5

Group means were not significantly different. ILBD = incidental Lewy body disease; PD = Parkinson’s disease; DLB = dementia with Lewy bodies; ADLB = Alzheimer’s disease with Lewy bodies; ADNLB = Alzheimer’s disease with no Lewy bodies.